ALknee Follow-up Study of the Cementless ATTUNE Rotating Platform and the Cementless LCS Rotating Platform Knee System

April 16, 2024 updated by: Raymond Puijk, Spaarne Gasthuis

Comparing the Migration and Inducible Displacement Through RSA of the Cementless ATTUNE Rotating Platform and the Cementless LCS Rotating Platform Knee System; A Clinical Randomized Controlled RSA Follow-up Study

The cementless ATTUNETM Rotating Platform Knee system was compared in a single-blind, randomized RSA trial to its predecessor, the LCS rotating platform Knee System. In this previous study, 61 knees were subjected to RSA examinations at 1-day and 3, 6, 12 and 24 months postoperative. This study found a promising equal migration of both tibial components and a lesser migration of the femoral component of the ATTUNETM knee system after two years, although with a similar migration rate between year 1 and 2. this raises the question of whether the migration of the prostheses relative to each other will increase or remain the same in the long term. To examine this, a mid-and long-term RSA follow-up to measure migration is necessary. In addition, another new RSA measurement parameter has become known in recent years that may provide an indication of the bonding of the prosthesis to the bone at the time of measurement. This new parameter, called the Induced Displacement (ID) of a prosthesis, measures the position and orientation relative to the bone while the prosthesis is under different loading conditions (e.g., patient in supine or standing position). This means that a large measured difference between these different loading condition measurements would indicate that osseointegration of the prosthesis never occurred or is no longer present. To improve the understanding of the tendency of both prostheses to aseptic loosening after a mid- to long-term follow up, migration over time and inducible displacement analyses are necessary.

The primary objective of this study is to accurately compare mid- and long-term migration of two uncemented TKR prostheses. The secondary objectives of this study are to evaluate if inducible displacement can be used as a parameter to detect loose implants, and to compare inducible displacement, clinical and radiological outcome and patient-reported outcomes (PROMS) after a follow-up of 5 and 10 years of two uncemented TKR prostheses.

Study Overview

Study Type

Observational

Enrollment (Actual)

49

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord-Holland
      • Hoofddorp, Noord-Holland, Netherlands, 2134TM
        • Spaarne Gasthuis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

In this study, all subjects that participated in the initial study (ALknee study - NL58911.058.16) will be asked to participate. All these patients underwent a TKA for symptomatic osteoarthritis of the knee in the period of August 2017 and March 2018 at the Department of Orthopaedics in the Spaarne Gasthuis, Hoofddorp, The Netherlands.

Description

Inclusion Criteria:

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

  • The Patient participated in the initial study (NL58911.058.16) [1].
  • The patient is capable of giving informed consent and expressing a willingness to comply with the study.

Exclusion Criteria:

A potential subject who meets any of the following criteria will be excluded from participation in this study:

  • The patient underwent a major revision TKR (exchange of the tibial or femoral component).
  • The patient is unable or unwilling to sign the informed consent specific to this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cementless ATTUNE
Cementless ATTUNE Rotating Platform Cruciate Sacrificing Knee System
RSA radiographs will be made 5 and 10 years after the total knee arthroplasty.
Cementless LCS
Cementless LCS rotating platform Cruciate Sacrificing Knee System
RSA radiographs will be made 5 and 10 years after the total knee arthroplasty.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline migration of the prostheses
Time Frame: 5 years post TKA
Migration is measured and expressed in translations, rotations, and MTPM; MTPM is the point of the prosthesis that has moved most.
5 years post TKA
Ten year change from baseline migration of the prostheses
Time Frame: 10 years post TKA
Migration is measured and expressed in translations, rotations and MTPM; MTPM is the point of the prosthesis that has moved most.
10 years post TKA

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inducible displacement
Time Frame: 5 years post TKA
The inducible displacement is defined as the difference in translation (MTPM) between a measurement without external force (e.g., supine position) and a measurement with external force (e.g., weight bearing) minus the measurement error.
5 years post TKA
Inducible displacement
Time Frame: 10 years post TKA
The inducible displacement is defined as the difference in translation (MTPM) between a measurement without external force (e.g., supine position) and a measurement with external force (e.g., weight bearing) minus the measurement error.
10 years post TKA
EuroQol 5D-5L (EQ-5D-5L)
Time Frame: 5 year post TKA
A patient reported outcome score for assessing mental well-being by using a score from 0 to 1, with 0 = worse and 1 = best.
5 year post TKA
EuroQol 5D-5L (EQ-5D-5L)
Time Frame: 10 year post TKA
A patient reported outcome score for assessing mental well-being by using a score from 0 to 1, with 0 = worse and 1 = best.
10 year post TKA
Knee injury and Osteoarthritis Outcome Scale Physical Function Short-form (KOOS-PS)
Time Frame: 5 year post TKA
A 7-item patient reported outcome score that measures daily physical functioning by using a score of 0 to 100, with 0 = no problems and 100 = extreme problems.
5 year post TKA
Knee injury and Osteoarthritis Outcome Scale Physical Function Short-form (KOOS-PS)
Time Frame: 10 year post TKA
A 7-item patient reported outcome score that measures daily physical functioning by using a score of 0 to 100, with 0 = no problems and 100 = extreme problems.
10 year post TKA
Oxford-12 Knee Score (OKS)
Time Frame: 5 year post TKA
A 12-item patient-reported outcome score to assess function and pain after total knee arthroplasty. The score uses a score of 0 to 48, with 0 = worse and 48 = best.
5 year post TKA
Oxford-12 Knee Score (OKS)
Time Frame: 10 year post TKA
A 12-item patient-reported outcome score to assess function and pain after total knee arthroplasty. The score uses a score of 0 to 48, with 0 = worse and 48 = best.
10 year post TKA
Kujala Anterior Knee Pain Scale (AKPS)
Time Frame: 5 year post TKA
A 13-item patient reported outcome score for assessing daily anterior knee pain, by using a score from 0 to 100, with 0 = having anterior knee pain with disabilities and 100 = no signs of anterior knee pain.
5 year post TKA
Kujala Anterior Knee Pain Scale (AKPS)
Time Frame: 10 year post TKA
A 13-item patient reported outcome score for assessing daily anterior knee pain, by using a score from 0 to 100, with 0 = having anterior knee pain with disabilities and 100 = no signs of anterior knee pain.
10 year post TKA
Numeric Rating Scale (NRS)
Time Frame: 5 year post TKA
A patient reported outcome score for assessing pain by using a likert scale from 0 to 10, with 0 = no pain and 10 = severe pain)
5 year post TKA
Numeric Rating Scale (NRS)
Time Frame: 10 year post TKA
A patient reported outcome score for assessing pain by using a likert scale from 0 to 10, with 0 = no pain and 10 = severe pain)
10 year post TKA
Anchor questions
Time Frame: 5 year post TKA

A patient reported outcome score for assessing change in functioning and pain since surgery.

The outcome is evaluated by use of a likert scale from 1 to 7, with 1 = much deteriorated and 7 = much improved).

5 year post TKA
Anchor questions
Time Frame: 10 year post TKA

A patient reported outcome score for assessing change in functioning and pain since surgery.

The outcome is evaluated by use of a likert scale from 1 to 7, with 1 = much deteriorated and 7 = much improved).

10 year post TKA

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: 5 year post TKA
Complications during follow-up will be reported
5 year post TKA
Complications
Time Frame: 10 year post TKA
Complications during follow-up will be reported
10 year post TKA

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter A. Nolte, Prof. MD, Spaarne Gasthuis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 10, 2022

Primary Completion (Estimated)

May 31, 2029

Study Completion (Estimated)

May 31, 2029

Study Registration Dates

First Submitted

November 3, 2022

First Submitted That Met QC Criteria

November 14, 2022

First Posted (Actual)

November 21, 2022

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • NL82000.058.22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Radiographs of the knee for radiostereometric analysis (RSA)

Subscribe